Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for periarticular inflammation refractory to NSAIDs and/or steroids
2013-005402-65Phase 2Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Apr 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of anakinra, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Pain intensity on VAS. Started Apr 2014; status: terminated.
02
Drugs
anakinra
Beyond the preview
Go deeper on 2013-005402-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005402-65.